Passage Bio, Inc. (PASG) Misses Q3 EPS by 8c
Tweet
Share
E-mailGet Alerts PASG Hot Sheet
Join SI Premium – FREE
Passage Bio, Inc. (NASDAQ: PASG) reported Q3 EPS of ($0.31), $0.08 worse than the analyst estimate of ($0.23).
For earnings history and earnings-related data on Passage Bio, Inc. (PASG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Deutsche Bank Upgrades Huizhou Desay Sv Automotive Co (002920:CH) to Hold
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
